KATHLEEN FUCHS: Open Payments
NPI 1326753492 · GERMANTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,812 in 146 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,941 · 2025 $2,812
Food & beverage: $2,712Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $580 |
| AstraZeneca Pharmaceuticals LP | 13 | $372 |
| Astellas Pharma US Inc | 7 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $228 |
| ABBVIE INC. | 18 | $222 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $115 |
| Otsuka America Pharmaceutical, Inc. | 7 | $113 |
| Lilly USA, LLC | 8 | $109 |
| Amgen Inc. | 6 | $103 |
| Sumitomo Pharma America, Inc. | 5 | $92 |
Products named: Ozempic, AIRSUPRA, CAPLYTA, VRAYLAR, REXULTI, Veozah, Kerendia, MOUNJARO.
Industry payments across OH — which companies pay providers there.
